IRIS Accounts Production v25.4.0.155 13954952 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh139549522024-03-31139549522025-03-31139549522024-04-012025-03-31139549522023-03-31139549522023-04-012024-03-31139549522024-03-3113954952ns15:EnglandWales2024-04-012025-03-3113954952ns14:PoundSterling2024-04-012025-03-3113954952ns10:Director12024-04-012025-03-3113954952ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3113954952ns10:SmallEntities2024-04-012025-03-3113954952ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3113954952ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3113954952ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3113954952ns10:FullAccounts2024-04-012025-03-3113954952ns10:RegisteredOffice2024-04-012025-03-3113954952ns5:CurrentFinancialInstruments2025-03-3113954952ns5:CurrentFinancialInstruments2024-03-3113954952ns5:ShareCapital2025-03-3113954952ns5:ShareCapital2024-03-3113954952ns5:RetainedEarningsAccumulatedLosses2025-03-3113954952ns5:RetainedEarningsAccumulatedLosses2024-03-3113954952ns5:ComputerEquipment2024-04-012025-03-3113954952ns5:ComputerEquipment2024-03-3113954952ns5:ComputerEquipment2025-03-3113954952ns5:ComputerEquipment2024-03-31
REGISTERED NUMBER: 13954952 (England and Wales)




















Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Endocover Ltd

Endocover Ltd (Registered number: 13954952)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Endocover Ltd

Company Information
for the Year Ended 31 March 2025







DIRECTOR: Dr G V Chandran





REGISTERED OFFICE: 63 Somerford Road
Cirencester
Gloucestershire
GL7 1US





REGISTERED NUMBER: 13954952 (England and Wales)

Endocover Ltd (Registered number: 13954952)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 305 600

CURRENT ASSETS
Debtors 6 42,500 -
Cash at bank 96,613 130,402
139,113 130,402
CREDITORS
Amounts falling due within one year 7 40,875 42,650
NET CURRENT ASSETS 98,238 87,752
TOTAL ASSETS LESS CURRENT
LIABILITIES

98,543

88,352

PROVISIONS FOR LIABILITIES 76 167
NET ASSETS 98,467 88,185

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 98,367 88,085
98,467 88,185

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 16 December 2025 and were signed by:





Dr G V Chandran - Director


Endocover Ltd (Registered number: 13954952)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Endocover Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on straight line basis

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Endocover Ltd (Registered number: 13954952)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

3. ACCOUNTING POLICIES - continued

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.

Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2024
and 31 March 2025 895
DEPRECIATION
At 1 April 2024 295
Charge for year 295
At 31 March 2025 590
NET BOOK VALUE
At 31 March 2025 305
At 31 March 2024 600

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 42,500 -

Endocover Ltd (Registered number: 13954952)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors - 1
Tax 12,747 13,418
Social security and other taxes 557 -
Directors' current accounts 26,497 28,217
Accruals and deferred income 1,074 1,014
40,875 42,650